(NASDAQ: ASPI) Asp Isotopes's forecast annual revenue growth rate of 107.07% is forecast to beat the US Chemicals industry's average forecast revenue growth rate of 5.36%, and it is also forecast to beat the US market's average forecast revenue growth rate of 14.02%.
Asp Isotopes's revenue in 2026 is $26,927,395.On average, 5 Wall Street analysts forecast ASPI's revenue for 2026 to be $4,220,157,640, with the lowest ASPI revenue forecast at $3,761,869,093, and the highest ASPI revenue forecast at $4,759,150,297. On average, 5 Wall Street analysts forecast ASPI's revenue for 2027 to be $11,262,189,238, with the lowest ASPI revenue forecast at $10,529,431,176, and the highest ASPI revenue forecast at $11,869,673,369.
In 2028, ASPI is forecast to generate $33,052,172,906 in revenue, with the lowest revenue forecast at $27,205,216,828 and the highest revenue forecast at $38,900,388,020.